MRND ISSUER
The MRV Mid-Cap Innovators ETF (MRND) is managed by IndexIQ Advisors LLC and seeks to passively track the performance of the Underlying Index, which was developed by IndexIQ LLC, an affiliate of the advisor. This ETF is designed to provide exposure to innovative U.S. mid-cap companies with significant research and development (R&D) spending, covering a market capitalization range of approximately $3.10 billion to $46.46 billion as of June 30, 2022. The primary sectors within the Underlying Index are consumer discretionary, health care, and information technology. MRND aims to invest at least 80% of its net assets in securities included in its Underlying Index, which consists of the top 100 eligible component securities with the highest R&D spending during the previous year. The Underlying Index is rebalanced quarterly and imposes component weight and sector weight caps to maintain diversification. Additionally, the ETF may invest in Affiliated ETFs advised by the same issuer to help track the Underlying Index effectively.
MRND DIVIDEND
The MRND Dividend ETF, while primarily focusing on tracking the performance of the Underlying Index developed by IndexIQ LLC, also offers investors exposure to dividends. This ETF's dividend distributions typically occur on a quarterly basis and are influenced by the dividend policies and performances of the US mid-cap companies within the Underlying Index. As of June 30, 2022, the Underlying Index encompasses innovative companies with high research and development spending, providing investors with an opportunity for both capital appreciation and potential dividend returns.
MRND TRACKING
The MRND Tracking ETF follows a passive management approach, aiming to replicate the performance of the Underlying Index, which was developed by IndexIQ LLC, the fund's affiliated investment advisor. This index is designed to provide exposure to innovative US mid-cap companies with significant research and development (R&D) spending, falling within a market capitalization range of approximately $3.10 billion to $46.46 billion as of June 30, 2022. The primary sectors represented in the Underlying Index are consumer discretionary, health care, and information technology. The ETF invests at least 80% of its net assets in the securities included in the Underlying Index, which consists of 100 eligible component securities with the highest R&D spending. These securities are weighted based on their R&D spending, subject to maximum component weight caps and sector weight caps, and the index is rebalanced quarterly. Additionally, the Underlying Index may include Affiliated ETFs, which the MRND Tracking ETF may invest in to help closely track the index's performance.
MRND CORRELATION
The correlation aspect of the IQ Merger Arbitrage ETF (MRND) is important in understanding its performance in the context of merger arbitrage strategies. MRND aims to track the performance of the IQ Merger Arbitrage Plus Index, which is designed to provide exposure to US companies involved in merger and acquisition activities. This ETF's correlation with the broader market may vary depending on the prevailing M&A landscape, making it a valuable tool for investors seeking to profit from corporate deals and related events. To delve deeper into MRND's correlations and gain valuable insights, investors can utilize the ETF Insider web app, which offers simple visualization tools and data to help assess overlaps and potential opportunities in the merger arbitrage space.
MRND SECTOR
The MRND Sector ETF focuses on innovative US mid-cap companies with a strong emphasis on research and development (R&D) spending. As of June 30, 2022, the primary sectors within the Underlying Index are consumer discretionary, health care, and information technology. This ETF provides exposure to companies that are at the forefront of technological advancements and product development. It follows a passive management approach to track the performance of the Underlying Index, which is carefully constructed to include firms with significant R&D investments, making it an attractive option for investors seeking potential growth opportunities. However, investors should be aware of the higher risk profile associated with this concentrated sector focus.
MRND EXPOSURE
The exposure characteristic of the MRND ETF (MRND) is centered around innovative U.S. mid-cap companies with a focus on research and development (R&D) spending. This ETF aims to track the performance of the Underlying Index, which consists of US mid-cap companies with high R&D investment, showcasing their potential for growth and innovation. As of the latest available data, the market capitalization range of the Underlying Index falls between approximately $3.10 billion and $46.46 billion. The primary sectors represented in the Underlying Index include consumer discretionary, health care, and information technology. To explore this ETF''s exposure in detail and uncover valuable insights, investors can use the ETF Insider web app, which offers comprehensive data, visualizations, and the ability to analyze overlaps and correlations with other US ETFs.